Novo’s Wegovy successor disappoints in second large trial

A study in people with obesity and diabetes again found CagriSema helps people lose weight, but not by enough to clearly surpass Eli Lilly’s Zepbound.

Losing forest carbon stocks could put climate goals out of reach – Study – EnviroNews

March 29, 2025

Peter Marks, FDA’s top vaccine official, resigns

March 29, 2025

Source link

Novo’s Wegovy successor disappoints in second large trial

Losing forest carbon stocks could put climate goals out of reach – Study – EnviroNews

Peter Marks, FDA’s top vaccine official, resigns

At SXSW, Bluesky CEO Jay Graber pokes fun at Mark Zuckerberg with Latin phrase T-shirt

Tesla (TSLA) Stock May Get Boost From Trump Tariffs: Here’s How

Tesla (TSLA) Stock May Get Boost From Trump Tariffs: Here’s How

Leave a Reply Cancel reply

RECOMMENDED NEWS

COMMENTARY: D.C. Crime Bill Fails to Address Root Causes of Violence and Incarceration

Martha Karua’ stance on becoming Attorney General in Ruto’s Gov’t

G20 Leaders Agree To Triple Total Renewable Energy Capacity By $4 Trillion Annual Investments Until 2030

Research team works to improve AI-based decision-making tools for public services

POPULAR NEWS

When Will SHIB Reach $1? Here’s What ChatGPT Says

Matthew Slater, son of Jackson State great, happy to see HBCUs back at the forefront

Dolly Varden Focuses on Adding Ounces the Remainder of 2023

US Dollar Might Fall To 96-97 Range in March 2024

Mass Casualty At Concerts: Vaccinated Crowds ‘Die Suddenly”

Novo’s Wegovy successor disappoints in second large trial

Related posts

At SXSW, Bluesky CEO Jay Graber pokes fun at Mark Zuckerberg with Latin phrase T-shirt

Tesla (TSLA) Stock May Get Boost From Trump Tariffs: Here’s How

Leave a Reply Cancel reply

RECOMMENDED NEWS

POPULAR NEWS